FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

24508111000001106: Inlyta 3mg tablets (Pfizer Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79460001000001114 Inlyta 3mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79460101000001110 Inlyta 3mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inlyta 3mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Is a Axitinib 3mg tablets true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has active ingredient Axitinib true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has specific active ingredient Axitinib true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Is a Inlyta true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inlyta 3mg tablets (Pfizer Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Inlyta 3mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has AMP True Inlyta 3mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start